Indian Pharma Companies
-
{
- All
- News
- Videos
-
Weight Loss Injection For ₹900? Three Pharma Firms Launch Affordable Semaglutide, Check Prices
- Saturday March 21, 2026
- Feature | Edited by Nikhil Pandey
Indian pharmaceutical companies have launched affordable versions of semaglutide injections following a patent expiry, significantly lowering costs for diabetes and weight management treatment and improving access for millions of patients.
-
www.ndtv.com
-
Indian Pharma Giants Launch Low-Cost Generic Semaglutide Injections For Diabetes, Weight Management
- Saturday March 21, 2026
- Health | Indo-Asian News Service
New Delhi, March 21 (IANS) Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost options for patients managing Type 2 diabetes and obesity.
-
www.ndtv.com
-
Central Drugs Body Revamps Testing Permissions To Fast-Track Drug Approvals in India
- Thursday February 26, 2026
- Health | Written by Shreya Goswami
India's drug regulator Central Drugs Standard Control Organization has revised testing permission norms to speed up approvals. From June 1, 2026, companies can start lab testing immediately after application, a step aimed at reducing delays while mai
-
www.ndtv.com
-
India-US Trade Deal Likely To Offer Tariff Relief On Exported Medicines
- Wednesday February 11, 2026
- Health | Indo-Asian News Service
India's pharmaceutical industry has welcomed the interim trade agreement framework between India and the US, which offers tariff relief on medicines and several other Indian exports.
-
www.ndtv.com
-
India-EU Trade Pact Explained: $572 Billion Boost To Indian Pharma, MedTech Industry
- Wednesday January 28, 2026
- Health | Written by NDTV Health Desk, Edited by Shreya Goswami
The India-EU Free Trade Agreement opens access to the European Union's $572.3 billion pharmaceuticals and medical devices market, boosting India's pharma sector, employment, MSMEs and global supply chain integration, according to the government.
-
www.ndtv.com
-
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
- Monday January 26, 2026
- Health | Indo-Asian News Service
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).
-
www.ndtv.com
-
India To Become Global Innovation-Led Pharma Giant In 5 Years: Central Drugs Body Says
- Wednesday November 26, 2025
- Health | Indo-Asian News Service
India is well positioned to evolve from being the pharmacy of the world to an innovation-led pharma nation over the next five years, said Dr. R Chandrashekar, Joint Drugs Controller, the Central Drugs Standard Control Organization (CDSCO).
-
www.ndtv.com
-
Who Is Rama Raju Mantena? The Indian-American Pharma Titan Behind Viral Udaipur Wedding
- Sunday November 23, 2025
- Feature | Edited by Ritu Singh
Rama Raju Mantena is a prominent figure in the US pharmaceutical industry, serving as the Chairman and CEO of Ingenus Pharmaceuticals, a company with operations in the US, Switzerland, and India.
-
www.ndtv.com
-
New Study Highlights Drug Pricing And Regulation Issues In India
- Wednesday November 12, 2025
- Health | Written by Rupashi Chhabra
A new government study exposes serious flaws in India's drug pricing and regulation infrastructure. This study reveals how systemic failures impact drug pricing.
-
www.ndtv.com
-
Weight Loss Injection For ₹900? Three Pharma Firms Launch Affordable Semaglutide, Check Prices
- Saturday March 21, 2026
- Feature | Edited by Nikhil Pandey
Indian pharmaceutical companies have launched affordable versions of semaglutide injections following a patent expiry, significantly lowering costs for diabetes and weight management treatment and improving access for millions of patients.
-
www.ndtv.com
-
Indian Pharma Giants Launch Low-Cost Generic Semaglutide Injections For Diabetes, Weight Management
- Saturday March 21, 2026
- Health | Indo-Asian News Service
New Delhi, March 21 (IANS) Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost options for patients managing Type 2 diabetes and obesity.
-
www.ndtv.com
-
Central Drugs Body Revamps Testing Permissions To Fast-Track Drug Approvals in India
- Thursday February 26, 2026
- Health | Written by Shreya Goswami
India's drug regulator Central Drugs Standard Control Organization has revised testing permission norms to speed up approvals. From June 1, 2026, companies can start lab testing immediately after application, a step aimed at reducing delays while mai
-
www.ndtv.com
-
India-US Trade Deal Likely To Offer Tariff Relief On Exported Medicines
- Wednesday February 11, 2026
- Health | Indo-Asian News Service
India's pharmaceutical industry has welcomed the interim trade agreement framework between India and the US, which offers tariff relief on medicines and several other Indian exports.
-
www.ndtv.com
-
India-EU Trade Pact Explained: $572 Billion Boost To Indian Pharma, MedTech Industry
- Wednesday January 28, 2026
- Health | Written by NDTV Health Desk, Edited by Shreya Goswami
The India-EU Free Trade Agreement opens access to the European Union's $572.3 billion pharmaceuticals and medical devices market, boosting India's pharma sector, employment, MSMEs and global supply chain integration, according to the government.
-
www.ndtv.com
-
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
- Monday January 26, 2026
- Health | Indo-Asian News Service
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).
-
www.ndtv.com
-
India To Become Global Innovation-Led Pharma Giant In 5 Years: Central Drugs Body Says
- Wednesday November 26, 2025
- Health | Indo-Asian News Service
India is well positioned to evolve from being the pharmacy of the world to an innovation-led pharma nation over the next five years, said Dr. R Chandrashekar, Joint Drugs Controller, the Central Drugs Standard Control Organization (CDSCO).
-
www.ndtv.com
-
Who Is Rama Raju Mantena? The Indian-American Pharma Titan Behind Viral Udaipur Wedding
- Sunday November 23, 2025
- Feature | Edited by Ritu Singh
Rama Raju Mantena is a prominent figure in the US pharmaceutical industry, serving as the Chairman and CEO of Ingenus Pharmaceuticals, a company with operations in the US, Switzerland, and India.
-
www.ndtv.com
-
New Study Highlights Drug Pricing And Regulation Issues In India
- Wednesday November 12, 2025
- Health | Written by Rupashi Chhabra
A new government study exposes serious flaws in India's drug pricing and regulation infrastructure. This study reveals how systemic failures impact drug pricing.
-
www.ndtv.com